Requirement of the SH4 and tyrosine-kinase domains but not the kinase activity of Lyn for its biosynthetic targeting to caveolin-positive Golgi membranes

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1345-1352

  Ikeda, Kikuko ^a   Nakayama, Yuji ^a   Ishii, Mayuko ^a   Obata, Yuuki ^a   Kasahara, Kousuke ^a   Fukumoto, Yasunori ^a   Yamaguchi, Naoto ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Golgi caveolin; Kinase domain; Lipid modification; Lyn; Src family tyrosine kinase; Targeting

Indexed keywords

CAVEOLIN; MUTANT PROTEIN; PROTEIN KINASE LYN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GOLGI COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; PROTEIN TARGETING;

ANIMALS; BINDING SITES; CATALYTIC DOMAIN; CAVEOLINS; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOHEXIMIDE; GOLGI APPARATUS; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR MEMBRANES; MICROSCOPY, CONFOCAL; MUTATION; PROTEIN SYNTHESIS INHIBITORS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; TRANSFECTION;

EID: 69949106681     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.009     Document Type: Article

References (34)

1. Thomas S.M., and Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13 (1997) 513-609
2. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
3. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
4. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., and Courtneidge S.A. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20 (2000) 9018-9027
5. Resh M.D. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76 (1994) 411-413
6. c-src with endosomal membranes in mammalian fibroblasts. J. Cell Biol. 118 (1992) 321-333
7. lck to the plasma membrane independently of CD4. J. Cell Biol. 137 (1997) 1029-1040
8. Kasahara K., Nakayama Y., Ikeda K., Fukushima Y., Matsuda D., Horimoto S., and Yamaguchi N. Trafficking of Lyn through the Golgi caveolin involves the charged residues on αE and αI helices in the kinase domain. J. Cell Biol. 165 (2004) 641-652
9. Kasahara K., Nakayama Y., Kihara A., Matsuda D., Ikeda K., Kuga T., Fukumoto Y., Igarashi Y., and Yamaguchi N. Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomes. Exp. Cell Res. 313 (2007) 2651-2666
10. Ikeda K., Nakayama Y., Togashi Y., Obata Y., Kuga T., Kasahara K., Fukumoto Y., and Yamaguchi N. Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity. Exp. Cell Res. 314 (2008) 3392-3404
11. Campbell E.J., McDuff E., Tatarov O., Tovey S., Brunton V., Cooke T.G., and Edwards J. Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. Br. J. Cancer 99 (2008) 1769-1774
12. Kasahara K., Nakayama Y., and Yamaguchi N. v-Src and c-Src, nonpalmitoylated Src-family kinases, induce perinuclear accumulation of lysosomes through Rab7 in a kinase activity-independent manner. Cancer Lett. 262 (2008) 19-27
13. Matsuda D., Nakayama Y., Horimoto S., Kuga T., Ikeda K., Kasahara K., and Yamaguchi N. Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp. Cell Res. 312 (2006) 1205-1217
14. Donato N.J., Wu J.Y., Stapley J., Gallick G., Lin H., Arlinghaus R., and Talpaz M. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood 101 (2003) 690-698
15. Ptasznik A., Nakata Y., Kalota A., Emerson S.G., and Gewirtz A.M. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat. Med. 10 (2004) 1187-1189
16. Santos C.D., Demur C., Bardet V., Prade-Houdellier N., Payrastre B., and Recher C. A critical role for Lyn in acute myeloid leukemia. Blood 111 (2008) 2269-2279
17. Contri A., Brunati A.M., Trentin L., Cabrelle A., Miorin M., Cesaro L., Pinna L.A., Zambello R., Semenzato G., and Donella-Deana A. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J. Clin. Invest. 115 (2005) 369-378
18. Kasahara K., Nakayama Y., Sato I., Ikeda K., Hoshino M., Endo T., and Yamaguchi N. Role of Src-family kinases in formation and trafficking of macropinosomes. J. Cell. Physiol. 211 (2007) 220-232
19. lck. Mol. Cell. Biol. 7 (1987) 237-243
20. Kuga T., Hoshino M., Nakayama Y., Kasahara K., Ikeda K., Obata Y., Takahashi A., Higashiyama Y., Fukumoto Y., and Yamaguchi N. Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface. Exp. Cell Res. 314 (2008) 2040-2054
21. Yamaguchi N., Nakayama Y., Urakami T., Suzuki S., Nakamura T., Suda T., and Oku N. Overexpression of the Csk homologous kinase (Chk tyrosine kinase) induces multinucleation: a possible role for chromosome-associated Chk in chromosome dynamics. J. Cell Sci. 114 (2001) 1631-1641
22. Sato I., Obata Y., Kasahara K., Nakayama Y., Fukumoto Y., Yokoyama K.K., Saito T., and Yamaguchi N. Differential trafficking of c-Src, Lyn, c-Yes, and Fyn is specified by the state of palmitoylation in the SH4 domain. J. Cell Sci. 122 (2009) 965-975
23. Griffiths G., Fuller S.D., Back R., Hollinshead M., Pfeffer S., and Simons K. The dynamic nature of the Golgi complex. J. Cell Biol. 108 (1989) 277-297
24. Watson R.T., Furukawa M., Chiang S.H., Boeglin D., Kanzaki M., Saltiel A.R., and Pessin J.E. The exocytotic trafficking of TC10 occurs through both classical and nonclassical secretory transport pathways in 3T3L1 adipocytes. Mol. Cell. Biol. 23 (2003) 961-974
25. Erpel T., Superti-Furga G., and Courtneidge S.A. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. EMBO J. 14 (1995) 963-975
26. Waksman G., Shoelson S.E., Pant N., Cowburn D., and Kuriyan J. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72 (1993) 779-790
27. Nichols B.J. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4 (2002) 374-378
28. Parton R.G., and Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8 (2007) 185-194
29. Podar K., and Anderson K.C. Caveolin-1 as a potential therapeutic target in multiple myeloma. Cancer Lett. 233 (2006) 10-15
30. Li S., Couet J., and Lisanti M.P. Src tyrosine kinases, Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J. Biol. Chem. 271 (1996) 29182-29190
31. Couet J., Li S., Okamoto T., Ikezu T., and Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 272 (1997) 6525-6533
32. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., and Kuriyan J. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3 (1999) 639-648
33. McCabe J.B., and Berthiaume L.G. Functional roles for fatty acylated amino-terminal domains in subcellular localization. Mol. Biol. Cell. 10 (1999) 3771-3786
34. Mosesson Y., Mills G.B., and Tarden Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 8 (2008) 835-850